Top Qs
Timeline
Chat
Perspective
Axogen
From Wikipedia, the free encyclopedia
Remove ads
Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida.[1] Axogen products are designed to remedy peripheral nerve damage.[2][3][4] In 2013 the company raised $18 million in its initial public offering (IPO).[5] Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes.[6] The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator.
 | The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. (May 2025) |
As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration (FDA) for clinical use.[citation needed]
Remove ads
See also
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads